Journal
CLINICAL AND EXPERIMENTAL NEPHROLOGY
Volume 14, Issue 2, Pages 137-143Publisher
SPRINGER
DOI: 10.1007/s10157-009-0247-6
Keywords
Angiotensin-converting enzyme inhibitor; Angiotensin receptor blocker; Blood pressure control; Chronic kidney disease; Glomerular filtration rate; Internship and residency
Categories
Ask authors/readers for more resources
We sought to evaluate the current state of chronic kidney disease (CKD) management in our academic internal medicine clinic. A retrospective review was carried out involving all patients with laboratory evidence of CKD enrolled in our clinic. We evaluated the rate of CKD recognition as well as compliance with standard guidelines. We further subdivided our results based on physician training level, presence of diabetes, recognition of CKD, age, and race. Factors that significantly improved recognition and treatment of CKD in our study included presence of diabetes (p < 0.001), black race (p = 0.013), younger age (p = 0.004), and treatment by a resident physician (p = 0.009). Recognition of stage 3 CKD was associated with significant increases in urine protein analysis (p < 0.001) and nephrology consultation (p < 0.001). Chronic kidney disease remains under-recognized and undertreated despite well-publicized guidelines and widespread use of routine eGFR reporting.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available